AbCellera Biologics Inc. earnings per share and revenue

ABCL earnings per share for the last quarter are -0.17 USD whereas the estimation was -0.12 USD which accounts for -36.61% surprise. Company revenue for the same period amounts to 6.51 M USD despite the estimated figure of 7.68 M USD. Estimated earnings per share for the next quarter are -0.13 USD, and revenue is expected to reach 7.58 M USD. Also watch annual changes over time to get a bigger picture of ABCL earnings per share and revenue dynamics.